Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
Real life insights on the treatment of aTTP and the use of Cablivi in Belgium for the individual reimbursement revision of Cablivi Last updated: 2023-02-03 03:36
Quantitative reverse transcription polymerase chain reaction results as a non-biased powerful epidemiological indicator Last updated: 2023-02-03 03:36